This statistic depicts the number of currently active novel disease-modifying clinical trials for Alzheimer's disease drugs globally as of ***, by strategy. At that time there were ** active trials that utilized amyloid pathway strategies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Biotechnology Innovation Organization. (May 14, 2019). Total number of global novel disease-modifying clinical programs for Alzheimer's disease drugs in early 2019, by strategy [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. "Total number of global novel disease-modifying clinical programs for Alzheimer's disease drugs in early 2019, by strategy." Chart. May 14, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. (2019). Total number of global novel disease-modifying clinical programs for Alzheimer's disease drugs in early 2019, by strategy. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. "Total Number of Global Novel Disease-modifying Clinical Programs for Alzheimer's Disease Drugs in Early 2019, by Strategy." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 May 2019, /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization, Total number of global novel disease-modifying clinical programs for Alzheimer's disease drugs in early 2019, by strategy ÌÇÐÄÆƽâ°æ, /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/ (last visited July 31, 2026)
Total number of global novel disease-modifying clinical programs for Alzheimer's disease drugs in early 2019, by strategy [Graph], Biotechnology Innovation Organization, May 14, 2019. [Online]. Available: /statistics/1029579/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-strategy/
